Syndax Pharmaceuticals, Inc. ( SNDX) - Key Metrics
SNDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.82 | -$0.55 | -$0.34 | -$0.34 |
| 2026Q1 | $0.75 | -$0.49 | -$0.58 | -$0.58 |
| 2025Q4 | $0.79 | -$0.79 | -$0.80 | -$0.80 |
| 2025Q3 | $0.53 | -$0.70 | -$0.81 | -$0.82 |
| 2025Q2 | $0.44 | -$0.83 | -$1.02 | -$1.02 |
SNDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.94 |
| 2026Q1 | 0% | -11.92 |
| 2025Q4 | 0% | -6.73 |
| 2025Q3 | 0% | -5.50 |
| 2025Q2 | 0% | -2.82 |
SNDX
Price: $19.84
52 week price:
Earnings Per Share: -2.51 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 44479
Ebitda: -15.3 millionMarket Capitalization: 1.8 billion